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was induced in all rabbits by intermittent high-cholesterol diet and
endothelial denudation. From the ninth week, the rabbits in group P
received pioglitazone (10 mg$kg-1$d-1) in addition to the diet, till the
end of experiment. PET/CT scans were performed at 8 week and 18
week in all survival rabbits, to obtain FDG uptake parameters (mean
standardized uptake value, SUVmean and maximal standardized up-
take value, SUVmax). Concomitantly, serum samples were obtained
for analysis of blood glucose (G), triglycerides (TG), total cholesterol
(Ch), HDL, LDL, hs-CRP and MMP-9. All survival rabbits underwent 2
pharmacological triggerings to induce plaque rupture at 18 week. Af-
ter pharmacological triggering, all rabbits were euthanatized, aortic
histopathological analysis were performed.
CONCLUSIONS Pioglitazone can decrease the incidence of thrombotic
events and attenuate plaque vulnerability by ways of modulating
vascular inﬂammation, decreasing plaque area and neovessels. 18F
FDG PET/CT, seems capable of monitoring inﬂammation in asses anti-
atherosclerotic effect of pioglitazone.
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OBJECTIVES Previous studies have indicated that immune-inﬂam-
matory activation plays an important role in the development of
myocardial remodeling in patients with chronic heart failure. Cardiac
ﬁbroblast (CFb) plays a central role in the pathogenesis of myocardial
ﬁbrosis. Triptolide (TPL), PG-490, is a diterpene triepoxide with
potent immunosuppressive and anti-inﬂammatory properties and has
been used in China for centuries to treat immune-related disorders.
However, the effects of TPL on myocardial ﬁbrosis remain unclear.
The objective of this study was to determine whether TPL can protect
myocardial ﬁbrosis by inhibiting the proliferation of CFbs.
METHODS Myocardial tissue in newborn rats was digested with low
concentration trypsin and collagenase. The CFbs and myocardial cells
were isolated with differential adherence method. Angiotensin II (10-7
mol/L) was used to promote the proliferation of CFbs. TPL (100 ng/ml)
was applied for 48 hours to inhibit CFbs proliferation. MTT assay was
used to detect cell survival rate in vitro. Flow cytometry was per-
formed to analyze apoptosis. Collagen concentration was measured
using the hydroxyproline assay kit. Quantitative real-time PCR was
used to detect the expression of TGF-b1 and Smad3.
RESULTS Compared to the control group, CFbs in the angiotensin II
treated group proliferated signiﬁcantly. However, compared to the
angiotensin II treated group, the cell survival rate (324.64157.95%
vs.123.3834.32%, P<0.01) and collagen concentration (10.674.03
mg/ml vs. 4.401.49 mg/ml, P¼0.01) in TPL treated group were
signiﬁcantly lower. TPL treatment also promoted apoptosis in angio-
tensin II treated CFbs. The apoptosis rates of the angiotensin II and
TPL treated groups were 0.920.61% and 4.320.43%, respectively.
Furthermore, compared against the angiotensin II treated group, TPL
treatment down-regulated the expression of TGF-b1 (1.361.22 vs.
0.660.15, P<0.01) and Smad3 (1.530.14 vs. 0.250.10, P<0.05)
mRNA levels signiﬁcantly in rat CFbs in vitro.
CONCLUSIONS Our ﬁndings indicate that TPL may inhibit angio-
tensin II induced cardiac ﬁbroblast proliferation by down-regulating
the TGF-b1/Smad3 signaling pathway. TPL may be a potential thera-
peutic drug for myocardial ﬁbrosis.
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OBJECTIVES L-carnitine is a carrier in the course of the fatty acids
Metabolism. The fatty acids Metabolic Processes is damaged when
myocardial ischemia. The aim of this study is to determine the effectsof L-carnitine with different dosage on left ventricular function and
hemodynamics in AMI rats.
METHODS AMI were conducted by ligating left anterior descending
branch in male SD rats. Rats were randomly assigned to one of the
following groups: AMI control group(n¼12), large dosage L-carnitine
group (120mg100g-1d-1, n¼12), middle dosage L-carnitine group
(60mg100g-1d-1, n¼13), small dosage L-carnitine group(30mg100g-
1d-1, n¼11). Sham operated rats(n¼10) were selected randomly as
non-infarction control group. L-carnitine was administered by direct
abdominal cavity’s injection for four weeks. Then echocardiography
examination and hemodynamic studies were performed.
RESULTS
1. Compared with the AMI groups, a signiﬁcant increase could be seen
in ejection fraction(EF, 68.085.98%, 68.205.52% ,65.3512.07%
respectively) and fractional shortening (FS, 33.474.24%,
34.524.19%, 31.387.60% respectively) among in small, middle and
large dosage L-carnitine groups(all P<0.01), and a signiﬁcant decrease
could be seen in left ventricular end-diastolic volume(LVEDV,
0.580.13ml, 0.630.27ml, 0.650.20ml respectively) and left ven-
tricular end- systolic volume(LVESV, 0.170.08ml, 0.200.12ml,
0.210.11ml respectively) in small, middle and large dosage L-carni-
tine groups, no signiﬁcant difference among the three L-carnitine
groups(P>0.05).
2. Compared with the AMI group, a signiﬁcant decrease could be seen
in left ventricular end-diastolic pressure (LVEDP, 0.929.06mmHg,
2.724.32mmHg, 2.997.45mmHg respectively)(all P<0.01), and
a signiﬁcant increase could be seen in left ventricular pres-
sure maximal rate of rise (þdp/dt, 4646.02650.26mmHg/s,
4821.39956.18mmHg/s, 4544.87617.77mmHg/s respectively)
(P<0.05), left ventricular pressure maximal rate of fall(-dp/dtmax,
4358.25700.65mmHg/s, 4360.79754.10mmHg/s, 4409.26
929.50mmHg/s respectively), and left ventricular systolic pressur-
e(LVSP, 84.856.22mmHg, 85.177.22mmHg, 87.4212.31 mmHg
respectively), no signiﬁcant difference in these indexes among the
small, middle and large dosage L-carnitine groups, and no signiﬁcant
difference in aortic systolic blood pressure( ASBP), aortic diastolic
blood pressure(ADBP), mean aortic pressure(MAP) and heart rate (HR)
among the three L-carnitine groups.
CONCLUSIONS Early treatment with L-carnitine in three dosages
could improve hemodynamic state and left ventricular function
effectively in AMI rats.
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OBJECTIVES To ﬁnd the best method of cardiac stem cell (CSC)
isolation and culture through comparing the effect of different
methods in laying cell adhesion agent and different serum concen-
trations in culture.
METHODS Experiment was conducted with healthy newborn wistar
rats (one day of birth). The heart tissues were digested with trypsin
and collagenase repeatedly after it was removed from the rat chest
under sterile conditions, then the digested tissues were cultured in
cell culture bottle laying with ﬁbronectin (FN). The ﬁrst passage cells
were cultured in the bottle laying with Poly -D- lysine (PDL). Compare
of the CSC numbers and proliferation was conducted among different
cell groups, which were the group cultured in bottles laying at 37 C
with the other one laying at room temperature, and the group
cultured by modiﬁed cardiosphere growing medium (CGM)(pre-
scription is IMDM, 11% fetal bovine serum, 1% penicillin and strep-
tomycin, 1% L- glutamic acid) with the other one by normal CGM
(prescription is IMDM, 10% fetal bovine serum, 1% penicillin and
streptomycin, 1% L- glutamic acid). The CSCs were identiﬁed by
immunohistochemistry.
RESULTS CSCs were isolated from myocardial tissue of neonatal rats
successfully, C-kit positive. FN and PDL coating at 37C can signiﬁ-
cantly promote cell adhesion, increase cell growth rate and reduce the
cell doubling time (p<0.05) comparing with that at room temperature.
Application of modiﬁed CGM may accelerate cell growth speed and
reduce the cell doubling time (p<0.05).
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coating cell culture bottles and modiﬁed CGM is a more superior
method, which lays the foundation for the further experimental
study.
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OBJECTIVES To explore the protective effect of rosiglitazone on in-
sulin resistance (IR) induced by high glucose in vascular endothelial
cells and its possible mechanism.
METHODS Human umbilical vein endothelial cells (HUVECs) was
divided into 3 groups: the normal control group cultivated in DEME
medium with 5.5 mmol/L glucose; the high glucose group (HG)
cultivated in DEME medium with 33 mmol/L glucose for 24 h after the
IR model was set up; the rosiglitazone group cultivated in DEME
medium with 33 mmol/L glucose and 10 mmol/L of rosiglitazone for
24 h after the IR model was set up. The cell viability, nitric oxide(NO),
endothelin-1(ET-1), mitochondrial membrane potential, reactive oxy-
gen species(ROS), p-IKK and IkBa protein levels were detected.
RESULTS Compared with the normal control, the cell viability, the
level of NO and the mitochondrial membrane potential were
decreased, levels of ET-1 and ROS increased, p-IKK expression was
upregulated, and IkBa expression was down-regulated in HG group(all
P<0.01). Rosiglitazone reversed these changes(P<0.05).
CONCLUSIONS Rosiglitazone has the protective effect on insulin
resistance induced by high glucose in vascular endothelial cells via
inhibiting ROS/IKK signaling pathway.GW26-e2914
A study of the mechanism of valsartan pre-protecting adriamycin-induced
cardiotoxicity
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OBJECTIVES To investigate the effects of valsartan pre-protects
adrimycin-induced cardiotoxicity and the mechanism.
METHODS 61 of 8w SD rats were devided into 4groups as follows:
Control group (n¼9) were feeded normally; adrimycin-induced car-
diotoxicity() group:intraperitoneal ADR,2.5mg/(kg.w), totally 6 weeks,
cumulative dose was 15mg/kg. Group C (n¼17): valsartan (low dose)
intervened (VLD) group, Group D: valsartan(high dose) intervened
group(VHD). In group C and D, valsartan was separately (10mg/(kg.d)
and30mg/(kg.d)) given from the ﬁrst dose of adriamycin, totally 6
weeks. After 6 weeks administration of valsartan and adriamycin,
observed 4 weeks. Use echocardiography to detect LVEF, LVFS,
LVESD, LVEDD. Take the heart out of the chest to do measure hearts’
weight. And then do HE, Sirius red staining. Count out CVF. Use ELISA
kits to detect the content of RAS and ROS in cardiac tissues. Use qRT-
PCR to detect collagen I, collagen III, caspase3 and caspase8’s
expressions.
RESULTS
(1) Compared with blank control group, renin, angiotensin II, aldoste-
rone synthase, ROS in the myocardial tissues of the model group are
evidently overexpressed (P <0.05); In group model, rats’ myocardial
tissue, caspase3, caspase8 mRNA levels increased signiﬁcantly
(P <0.05), the myocardial collagen volume increased signiﬁcantly
(P<0.05).
(2) Valsartan high dose group compared with blank control group, there
was no signiﬁcant statistical differences about indexes above (P
>0.05). compared with model control group, the valsartan high dose
group and the blank control group, there were signiﬁcant differences
about the above indexes (P < 0.05).
(3) There were no signiﬁcant differences in LVEDD among the four
groups (P >0.05); About LVESD, LVEF, LVFS, there were no signiﬁ-
cant difference between the valsatan low dose group and the model
control group. The above index average were less than the model
control group and the valsartan low dose group, The differences
among the three groups were signiﬁcant (P <0.05), Compared with
the high dose group and the blank control group, the above indexes
in model control group were higher. The differences were
signiﬁcant(P <0.05). There were no difference between the valsartan
high dose group and blank control group (P >0.05).CONCLUSIONS
(1) Adriamycin might via activing RAS in rats’ myocardial tissues to
cause angiotensin overexpressed. Angiotensin-stimulatied to
generate more ROS. So the superabundant ROS caused the myocar-
dial apoptosis and ﬁbrosis.
(2) Appling enough dose (load dose) valsartan from the ﬁrst dose of
adriamycin could against AT1 in rats’ myocardial tissues. So it could
down-regulate the expression of NOX1 and NOX4 and the ROS
decreased. In the end, the myocardial apoptosis and ﬁbrosis would
be alleviated. However early application of small dose valsartan had
no protective effect on adriamycin induced cardiotoxicity.
(3) Sufﬁcient and early use of valsartan in adriamycin chemotherapy
rats could prevent rats suffering Cardiotoxicity. The mechanism
might related to NOX1 and NOX4 mediated oxidative stress.GW26-e2924
Endothelial progenitor cells join in HHcy impaired angiogenesis
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OBJECTIVES During the last decade,we and others have demonstrated
that HHcy can inhibit endothelial cell growth and postinjury reendo-
thelialization, accelerate neointimal formation, also can impair endo-
thelial relaxation, stimulate vascular smooth muscle cell proliferation,
and inhibit high-density lipoprotein biosynthesis. However, the
fundamental basis of HHcy-impaired angiogenesis remains unknown,
especially the role of endothelial progenitor cells in angiogenesis.
Role of endothelial progenitor cell in HHcy impaired angiogenesis.
Intravenous transfusions of Sca-1þ cells maybe play a role in HHcy MI
mice angiogenesis.
METHODS
1. Angiogenesis of HHcy mice under myocardial infarction. 1.1 Car-
diac function was measured with echocardiography (VisualSonics
Vevo 770); 1.2 Hearts were moved at 2 weeks/6 weeks after myocardial
infarction and kept at -80C until needed. Frozen heart tissues were
cut into 5mm thick slices. Adjacent sections (taken at the midpoint
between LAD ligation site and apex) were stained with rabbit poly-
clonal antibodies against CD31.
2. Flow cytometry analysis. A volume of 200ml peripheral blood/
bone marrow were incubated for 30 minutes in the dark with mono-
clonal antibodies against mouse vascular endothelial growth factor
receptor 2 (VEGFR2) followed by PE-conjugated secondary antibody.
3. MACS Separation-purify Sca-1þ cells. Purity of Sca-1þ cell is based
on the use of MACS MicroBeads, MACS Columns and MACS Separators.
4. Intravenous transfusions of Sca-1þ cells in HHcy MI mice angio-
genesis. To evaluate the homing to infarcted heart of injected cells,
200ml puriﬁed Sca-1þ cells were labeled with CellVueR NIR (near-
infrared) 780 (Excitation max: 745nm/Emission max: 776nm, Mol.
Targeting Tech. Inc. West Chester, PA) and injected peri-orbitally into
C57/B6 mice, 6 hours before MI procedure.
RESULTS
1. HHcy impairs mouse cardiac function. Ejection fraction (EF) and
fractional shortening (FS) were lower in HHcy mice group than control
group, as well as heart capillary density. HHcy mice hearts have
depressed function and less capillary density after myocardial
infarction stress. Survival rate is also lower in HHcy mice.
2. Peripheral blood derived EPC percentage decreased in HHcy mice
group and bone marrow derived EPC percentage is higher in HHcy
mice group, but cell death rate is also higher in HHcy mice.
3. Intravenous transfusion of Sca-1þ cells treatment induce PB derived
EPC percentage increase in both control mice group and HHcy mice
group. 6 weeks survival rate increased from 12.5% to 27.3% in
hCBSþCbs-/- cell treat group, and also 62.5% to 80% in hCBSþCbsþ/- cell
treat group; The LVEF increased from 19.3% to 38.5% in hCBSþCbs-/- cell
treat group, and also 31.6% to50.9% in hCBSþCbsþ/- cell treat group.
CONCLUSIONS EPC joined angiogenesis after myocardial infarction
which is so important to cardiac function. Cell treatment restores
ischemia-induced angiogenesis in HHcy mice.
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